Pre‐analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients-Reference-Cited by-同舟云学术

Pre‐analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients

Published:2020-04-04 Issue:5 Volume:14 Page:1001-1015
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Schneegans Svenja¹^ORCID,Lück Lelia¹,Besler Katharina¹,Bluhm Leonie²,Stadler Julia‐Christina¹³,Staub Janina³,Greinert Rüdiger²,Volkmer Beate²^ORCID,Kubista Mikael⁴⁵,Gebhardt Christoffer³,Sartori Alexander⁶,Irwin Darryl⁶,Serkkola Elina⁷,Hällström Taija⁷,Lianidou Evi⁸,Sprenger‐Haussels Markus⁹¹⁰,Hussong Melanie⁹¹⁰,Mohr Peter²,Schneider Stefan W.³,Shaffer Jonathan⁹¹⁰,Pantel Klaus¹^ORCID,Wikman Harriet¹^ORCID

Affiliation:

1. Department of Tumor Biology University Medical Center Hamburg‐Eppendorf Germany

2. Centre of Dermatology Elbe Clinics Buxtehude Germany

3. Department of Dermatology and Venereology University Medical Center Hamburg‐Eppendorf Germany

4. TATAA Biocenter AB Gothenburg Sweden

5. Department of Gene Expression Institute of Biotechnology Czech Academy of Sciences Vestec Czech Republic

6. Agena Bioscience GmbH Hamburg Germany

7. Orion Pharma Orion Corporation Espoo Finland

8. Analysis of Circulating Tumor Cells Lab of Analytical Chemistry Department of Chemistry University of Athens Greece

9. QIAGEN Inc/GmbH Frederick MD USA

10. QIAGEN Inc/GmbH Hilden Germany

Funder

Innovative Medicines Initiative

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12669

Reference44 articles.

1. Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing

2. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy

3. Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets

4. Clinical utility of circulating non-coding RNAs — an update

5. Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome Profiles

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical applications of circulating tumor cells in patients with solid tumors;Clinical & Experimental Metastasis;2024-01-28

2. Circulating tumour DNA in colorectal cancer management;British Journal of Surgery;2023-05-16

3. The 10th Santorini conference: Systems medicine, personalised health and therapy. “The odyssey from hope to practice: Patient first. Keep Ithaca always in your mind”, Santorini, Greece, 23–26 May 2022;Frontiers in Genetics;2023-03-09

4. A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer;Scientific Reports;2023-02-15

5. Development and Validation of Molecular Assays for Liquid Biopsy Applications;Circulating Tumor Cells;2023